Opioid and Common Co-Ingestant Antidotes

Publisher： Nova Science Publishers, Inc.

ISSN： 1546-6965

Source： Journal of Drug Addiction, Education, and Eradication, Vol., Iss., 2015-07, pp. : 83-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Common Adverse Effects and Complications of Long‐Term Opioid Therapy

By  

PAIN MEDICINE, Vol. 16, Iss. S1, 2015-10 ,pp. : S1-S2

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA orders black box warnings for benzo‐opioid co‐Rx

By  

ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 28, Iss. 35, 2016-09 ,pp. : 5-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trends in opioid prescribing and co‐prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001–2010

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 8, 2015-08 ,pp. : 885-892

John Wiley & Sons Inc

Access to resources Recommend Favorite

Associations Between Migraine and the Most Common Psychiatric Co‐Morbidities

By  

HEADACHE, Vol. 58, Iss. 2, 2018-02 ,pp. : 346-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent Advances in the Development of Specific Antidotes for Target‐Specific Oral Anticoagulants

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 198-207

John Wiley & Sons Inc

Access to resources Recommend Favorite